Study Comparing Once Daily Dose of 900mg of TETA 4HCL Against Cuprior® (450mg Trientine Base, Twice Daily).

Clinical trial NCT06128954 · COMPLETED

Trial details

NCT number: NCT06128954
Sponsor: Orphalan
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Wilson's Disease

Start date: 2024-01-16
Primary completion: 2024-02-08
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.